Nuzenio

Into Capricor Therapeutics

Into Capricor Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-DemocratCarroll County Mirror-Democrat · Sun, 09 Aug 2026 16:00:00 GMTCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - PR NewswirePR Newswire · Sat, 08 Aug 2026 16:35:00 GMTCapricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR - PR NewswirePR Newswire · Sat, 08 Aug 2026 02:00:00 GMTCAPR Stock Sinks After-Hours: Capricor Launches Legal Fight Over DMD Therapy Rollout Ahead Of FDA Review - StocktwitsStocktwits · Fri, 07 Aug 2026 21:24:04 GMTCapricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 19:26:00 GMTKaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026 - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 15:30:00 GMTCAPR Shareholder Alert: Investors With Losses May Seek to - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 14:08:00 GMTState Street Corporation (NASDAQ: CAPR custodian) holds 5.9% of Capricor Therapeutics - Stock TitanStock Titan · Fri, 07 Aug 2026 12:54:45 GMT

Timeline

Sun, 09 Aug 2026 16:00:00 GMTBronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat
Sat, 08 Aug 2026 16:35:00 GMTCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
Sat, 08 Aug 2026 02:00:00 GMTCapricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR - PR Newswire
Fri, 07 Aug 2026 21:24:04 GMTCAPR Stock Sinks After-Hours: Capricor Launches Legal Fight Over DMD Therapy Rollout Ahead Of FDA Review - Stocktwits
Fri, 07 Aug 2026 19:26:00 GMTCapricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - The Globe and Mail
Fri, 07 Aug 2026 15:30:00 GMTKaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026 - The Globe and Mail

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Into Capricor Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.